BIOMAT Database Logo BIOMAT Database Logo

Central effects of endothelin-1 on vasopressin and atrial natriuretic peptide release and cardiovascular and renal function in conscious rats. 1991

T Yamamoto, and T Kimura, and K Ota, and M Shoji, and M Inoue, and K Sato, and M Ohta, and K Yoshinaga
Second Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.

In order to investigate the central effect of endothelin-1 (ET-1) on arginine vasopressin (AVP) and atrial natriuretic peptide (ANP) release and cardiovascular and renal function, either a high dose of ET-1 (3.5 ng/kg/min, HET-1) or a low dose (0.35 ng/kg/min, LET-1) was administered into the cerebral third ventricle in conscious rats. ET-1 increased the mean arterial blood pressure, but not heart rate, in a dose-related manner. LET-1 slightly stimulated AVP release, but not ANP release. HET-1 increased plasma AVP and ANP. Pretreatment with a V1-antagonist (TMeAVP) attenuated the blood pressure response to ET-1 and completely abolished increases in plasma ANP. Moreover, prazosin given i.v. completely prevented the residual pressure response. ET-1 did not significantly affect renal electrolytes and water handling. These results suggest that centrally administered ET-1 may increase the activity of the sympathetic nervous system and vasopressinergic neurons, resulting in an increase in blood pressure.

UI MeSH Term Description Entries
D007276 Injections, Intraventricular Injections into the cerebral ventricles. Intraventricular Injections,Injection, Intraventricular,Intraventricular Injection
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D009320 Atrial Natriuretic Factor A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS. ANF,ANP,Atrial Natriuretic Peptide,Atrial Natriuretic Peptides,Atriopeptins,Auriculin,Natriuretic Peptides, Atrial,ANF (1-126),ANF (1-28),ANF (99-126),ANF Precursors,ANP (1-126),ANP (1-28),ANP Prohormone (99-126),ANP-(99-126),Atrial Natriuretic Factor (1-126),Atrial Natriuretic Factor (1-28),Atrial Natriuretic Factor (99-126),Atrial Natriuretic Factor Precursors,Atrial Natriuretic Factor Prohormone,Atrial Natriuretic Peptide (1-126),Atrial Pronatriodilatin,Atriopeptigen,Atriopeptin (1-28),Atriopeptin (99-126),Atriopeptin 126,Atriopeptin Prohormone (1-126),Cardiodilatin (99-126),Cardiodilatin Precursor,Cardionatrin I,Cardionatrin IV,Prepro-ANP,Prepro-CDD-ANF,Prepro-Cardiodilatin-Atrial Natriuretic Factor,Pro-ANF,ProANF,Proatrial Natriuretic Factor,Pronatriodilatin,alpha ANP,alpha-ANP Dimer,alpha-Atrial Natriuretic Peptide,beta-ANP,beta-Atrial Natriuretic Peptide,gamma ANP (99-126),gamma-Atrial Natriuretic Peptide,Natriuretic Peptide, Atrial,Peptide, Atrial Natriuretic,Peptides, Atrial Natriuretic,Prepro ANP,Prepro CDD ANF,Prepro Cardiodilatin Atrial Natriuretic Factor,Pro ANF,alpha ANP Dimer,alpha Atrial Natriuretic Peptide,beta ANP,beta Atrial Natriuretic Peptide,gamma Atrial Natriuretic Peptide
D011224 Prazosin A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION. Furazosin,Minipress,Pratsiol,Prazosin HCL,Prazosin Hydrochloride,HCL, Prazosin,Hydrochloride, Prazosin
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse

Related Publications

T Yamamoto, and T Kimura, and K Ota, and M Shoji, and M Inoue, and K Sato, and M Ohta, and K Yoshinaga
Effects of human atrial natriuretic peptide on renal function and vasopressin release.
May 1986, The American journal of physiology,
T Yamamoto, and T Kimura, and K Ota, and M Shoji, and M Inoue, and K Sato, and M Ohta, and K Yoshinaga
Effect of vasopressin on atrial natriuretic peptide release and renal function in dogs.
October 1988, The American journal of physiology,
T Yamamoto, and T Kimura, and K Ota, and M Shoji, and M Inoue, and K Sato, and M Ohta, and K Yoshinaga
[Central cardiovascular and renal effects of atrial natriuretic peptide].
December 1991, Sheng li xue bao : [Acta physiologica Sinica],
T Yamamoto, and T Kimura, and K Ota, and M Shoji, and M Inoue, and K Sato, and M Ohta, and K Yoshinaga
Atrial natriuretic peptide-induced effects are not dependent on intact central vasopressin secretion in conscious, fluid-balanced rats.
July 1993, Annals of the New York Academy of Sciences,
T Yamamoto, and T Kimura, and K Ota, and M Shoji, and M Inoue, and K Sato, and M Ohta, and K Yoshinaga
Central nitric oxide blocks vasopressin, oxytocin and atrial natriuretic peptide release and antidiuretic and natriuretic responses induced by central angiotensin II in conscious rats.
September 2007, Experimental physiology,
T Yamamoto, and T Kimura, and K Ota, and M Shoji, and M Inoue, and K Sato, and M Ohta, and K Yoshinaga
Atrial natriuretic peptide and endothelin: modulators of renal function.
September 1994, The Clinical investigator,
T Yamamoto, and T Kimura, and K Ota, and M Shoji, and M Inoue, and K Sato, and M Ohta, and K Yoshinaga
Inhibition of vasopressin and aldosterone release by atrial natriuretic peptide in conscious rabbits.
July 1992, Experimental physiology,
T Yamamoto, and T Kimura, and K Ota, and M Shoji, and M Inoue, and K Sato, and M Ohta, and K Yoshinaga
Central action of C-type natriuretic peptide on vasopressin secretion in conscious rats.
September 1993, Neuroscience letters,
T Yamamoto, and T Kimura, and K Ota, and M Shoji, and M Inoue, and K Sato, and M Ohta, and K Yoshinaga
Relationship between renal mass and atrial natriuretic peptide release. 2. Acute effects of various degrees of renal damage on atrial natriuretic peptide release in rats.
January 1994, Renal physiology and biochemistry,
T Yamamoto, and T Kimura, and K Ota, and M Shoji, and M Inoue, and K Sato, and M Ohta, and K Yoshinaga
Effects of angiotensin II, arginine-vasopressin, endothelin and catecholamines on plasma atrial natriuretic peptide concentrations in the conscious newborn calf.
July 1991, Journal of developmental physiology,
Copied contents to your clipboard!